Home > Pressemitteilung: New solutions for the RNA medicine of ... At the RNApp graduate school, young researchers are working to make RNA-based drugs safer and more effective.

Five researchers have been jointly awarded one of this year's Breakthrough Prizes in Life Sciences for their contributions to ...

The global lipid nanoparticles market, valued at US$ 820.51 million in 2023, is projected to experience significant growth, with an expected market valuation of US$ 2,387.98 million by 2032. This ...

Get Instant Summarized Text (Gist) Nearly 20% of U.S. adults have used multiple drugs in the past year, indicating complex substance use patterns. The study identifies four distinct drug use ...

Moderna is already riding high on the strength of its mRNA-based COVID-19 vaccine ... Seven of the patients received the drug during CABG, while four had a placebo injection.

PLC (AIM: 4BB) (“4basebio”), a company which develops and commercializes the large-scale manufacture of synthetic DNA as well as nanoparticle delivery solutions, today announced that it has received ...

A significant discovery has identified a missing "gatekeeper" protein as the root cause of dry mouth in Sjögren's syndrome — ...

South Korean researchers have, for the first time in the world, uncovered how messenger ribonucleic acid (mRNA) vaccines ...

National Drug and Alcohol Facts Week kicked off with a proclamation signing at the Office of the Governor on Tuesday, spotlighting the urgent need to confront substance abuse and its profound ...

In an ambitious move, Moderna has teamed up with OpenAI, the artificial intelligence company behind ChatGPT, to further integrate generative AI (GenAI) across its mRNA drug development and ...

How should continental vaccine manufacturers handle complex dynamics of supply and demand? ANALYSIS | The African Union has ...